0001145549-22-076046.txt : 20221214 0001145549-22-076046.hdr.sgml : 20221214 20221214113937 ACCESSION NUMBER: 0001145549-22-076046 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221214 DATE AS OF CHANGE: 20221214 EFFECTIVENESS DATE: 20221214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIP Alternative Lending Fund A CENTRAL INDEX KEY: 0001709447 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-23265 FILM NUMBER: 221461501 BUSINESS ADDRESS: STREET 1: 100 FRONT STREET, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428-2881 BUSINESS PHONE: 610.260.7600 MAIL ADDRESS: STREET 1: 100 FRONT STREET, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428-2881 N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001709447 XXXXXXXX false false false N-2 AIP Alternative Lending Fund A 811-23265 0001709447 549300LZHFSC1NZURF15 100 Front Street Suite 400 West Conshohocken 19428-2881 US-PA US 610-260-7600 U.S. Bancorp Fund Services LLC 615 East Michigan Street Milwaukee 53202 4147655604 The books and records required to be maintained by Section 31(a) of the Investment Company Act of 1940, as amended. N N N-2 Y Michael F. Klein N/A N Nancy C. Everett N/A N Patricia Maleski N/A N W. Allen Reed N/A N Jakki L. Haussler N/A N Dr. Manuel H. Johnson N/A N Joseph J. Kearns N/A N Frank L. Bowman N/A N Kathleen A. Dennis N/A N Frances L. Cashman N/A N Eddie A. Grier N/A N Dr. Manual H. Johnson N/A N Joesph J. Kearns N/A N Patricia A. Maleski N/A N Timothy J. Knierim N/A 522 Fifth Avenue New York 10036 XXXXXX N Deidre Downes N/A 1633 Broadway New York 10019 XXXXXX N N N N N N Morgan Stanley Distribution, Inc. 008-44766 000030344 54930020DF0S7EF78K71 Y N Ernst & Young LLP 00042 N/A N N N N N N N AIP Alternative Lending Fund A 549300LZHFSC1NZURF15 N Y N N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Y N Y N Morgan Stanley AIP GP LP 801-60699 000117050 549300KSRL5W75JNE398 N UMB Fund Services, Inc. 084-05792 N/A N N N Duff and Phelps LLC 549300W01Z54L5RHPJ40 N Kroll LLC 549300W01Z54L5RHPJ40 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Millenium Trust Company, LLC N/A N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N UMB Fund Services, Inc. 084-05792 SEC file number N N N U.S. Bancorp Fund Services, LLC N1GZ7BBF3NP8GI976H15 N N N Morgan Stanley Menkul Degerler A.S. N/A N/A 549300VJZV93UIORC566 TR 0.000000000000 Morgan Stanley Capital Services LLC N/A N/A I7331LVCZKQKX5T7XV54 0.000000000000 OOO Morgan Stanley Bank N/A N/A KXR3XGBYJIDK7XYBRF48 RU 0.000000000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 0.000000000000 Prime Dealer Services Corp. 8-47025 000036142 549300U1ZGT51W4F9866 0.000000000000 Morgan Stanley Gateway Securities JSC N/A N/A 5493007LT7NGWGYW4E84 VN 0.000000000000 Morgan Stanley Mexico, Casa de Bolsa, S.A. de C.V. N/A N/A FHYNAGT8UJJJOGL0BI58 MX 0.000000000000 Morgan Stanley Saudi Arabia N/A N/A 549300JYPS6Z0I1BVB86 SA 0.000000000000 PT Morgan Stanley Sekuritas Indonesia N/A N/A 549300JVGZMY503T1I56 ID 0.000000000000 RMB Morgan Stanley (Proprietary) Limited N/A N/A 54930026T33G80GFU737 ZA 0.000000000000 BIDS Holdings, L.P. (BIDS) N/A N/A N/A 0.000000000000 Morgan Stanley Hong Kong Securities Limited N/A N/A 549300SY0QG9QQ09KW20 HK 0.000000000000 EquiLend LLC. N/A N/A N/A 0.000000000000 Etrade Futures, LLC N/A N/A N/A 0.000000000000 Etrade Securities, LLC 8-53738 000119107 213800BN4DRR1ADYGP92 0.000000000000 Morgan Stanley & Co. International PLC N/A N/A 4PQUHN3JPFGFNF3BB653 GB 0.000000000000 Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. N/A N/A O7YCEUWQXFIO1CHULC69 JP 0.000000000000 Morgan Stanley Asia (Singapore) Securities Pte Ltd N/A N/A 549300JN2HN4WBKARP61 SG 0.000000000000 Morgan Stanley Canada Limited N/A N/A 54930065FO7CXEUTGL76 CA 0.000000000000 Morgan Stanley Asia (Singapore) Pte N/A N/A S7TFLKD0ZWWBHLSCAD37 SG 0.000000000000 Morgan Stanley Asia International Limited N/A N/A 549300OX8NDYIQ4DB571 HK 0.000000000000 Morgan Stanley Australia Securities Limited N/A N/A 6NYZXKE9GUP7XNI56S88 AU 0.000000000000 Morgan Stanley Distribution, Inc. N/A 000030344 54930020DF0S7EF78K71 0.000000000000 Morgan Stanley Corretora de Titulos e Valores Mobiliarios S.A. N/A N/A HN65QO5XTFJICDM5V937 BR 0.000000000000 Morgan Stanley Europe SE N/A N/A 54930056FHWP7GIWYY08 DE 0.000000000000 Morgan Stanley France S.A. N/A N/A PK168Q24DU7QQ2T4QF97 FR 0.000000000000 Morgan Stanley Wealth Management Canada Inc. N/A N/A 549300VVMTKCWZUZVJ61 CA 0.000000000000 Solium Financial Inc. N/A N/A N/A CA 0.000000000000 Morgan Stanley MUFG Securities Co., Ltd N/A N/A 549300OB5SQ53A8BTO30 JP 0.000000000000 Morgan Stanley India Company Private Limited N/A N/A OYO6KC46QF54MHNL5D43 IN 0.000000000000 Morgan Stanley Taiwan Limited N/A N/A 549300UX7BN34UFIPA91 TW 0.000000000000 Morgan Stanley S.V., S.A.U. N/A N/A 549300GSKN0B8BOS5L68 ES 0.000000000000 Morgan Stanley Smith Barney LLC 8-68191 000149777 7PDDXEMZ0ZV0CEDU4D16 0.000000000000 Morgan Stanley Wealth Management Australia Pty Ltd N/A N/A 549300VR74G9RZHCCE31 AU 0.000000000000 Morgan Stanley Saudi Arabia Company N/A N/A 549300JYPS6Z0I1BVB86 SA 0.000000000000 Eaton Vance Distributors, Inc. 8-47939 000037731 5493008E3UZUI6J6EL94 0.000000000000 Eaton Vance Management (International) Ltd. N/A 000281469 N/A GB 0.000000000000 EOS Precious Metals Limited N/A N/A 00000000000000000000 GB 0.000000000000 MEMX Holdings LLC N/A N/A 00000000000000000000 0.000000000000 Morgan Stanley Capital Products LLC N/A N/A IVNH9ABHJY5L0X3RKW69 0.000000000000 Morgan Stanley Capital Group Inc. N/A N/A VB7RXNZGO6KVDABYB880 0.000000000000 Morgan Stanley Bank, National Association N/A N/A G1MLHIS0N32I3QPILB75 0.000000000000 Morgan Stanley Senior Funding, Inc. N/A N/A XRR2REEVVJS58CENNG14 0.000000000000 Turquoise Global Holdings Ltd. N/A N/A 2138006SKBMJJUE2HV03 GB 0.000000000000 CREDITDERIV LIMTED N/A N/A 00000000000000000000 GB 0.000000000000 FXGLOBALCLEAR N/A N/A 00000000000000000000 GB 0.000000000000 OTCDERIV Limited N/A N/A 213800AJVXMIB2FPEM07 GB 0.000000000000 AFS Securities, LLC 8-69483 000171819 N/A 0.000000000000 Copeland Markets LLC N/A N/A 00000000000000000000 0.000000000000 Morgan Stanley Futures (China) Co., Ltd. N/A N/A 549300NIG5GTREINLK84 CN 0.000000000000 0.000000000000 SoFi Lending Corp. N/A N/A 549300SXISSKGPHW5702 120.760000000000 Lending Club Corporation N/A N/A N/A 38321684.080000000000 Upstart Network, Inc. N/A N/A N/A 1552356153.550000000000 Funding Circle Holdings Limited N/A N/A N/A GB 15018.820000000000 Prosper N/A N/A N/A 265187038.450000000000 Square N/A N/A N/A 357803262.100000000000 Marlette N/A N/A N/A 743175874.520000000000 Upgrade N/A N/A N/A 613847476.890000000000 3570706629.180000000000 N 2531085833.700830000000 Common stock Shares of Beneficial Interest N N N N N N 0.007500000000 2.260000000000 1033.910000000000 1033.910000000000 true INTERNAL CONTROL RPT 2 alf-a_internalcontrol.htm INTERNAL CONTROL REPORT

Report of Independent Registered Public Accounting Firm

To the Shareholders and
Board of Trustees of AIP Alternative Lending Fund A
 
In planning and performing our audit of the financial statements of AIP Alternative Lending Fund A (the Fund) as of and for the year ended September 30, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.
 
The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements.
 
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 
A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.
 
Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of September 30, 2022.
 
This report is intended solely for the information and use of management and the Board of Trustees of AIP Alternative Lending Fund A and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.
 

                                                                           /s/Ernst & Young LLP

Philadelphia, Pennsylvania
November 29, 2022